Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

Caitlin E. Cox

December 09, 2021

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

News Conference News TCT 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

Caitlin E. Cox

November 11, 2021

News Daily News

DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short

Yael L. Maxwell

October 27, 2021

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Daily News

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

Caitlin E. Cox

July 19, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

Podcast TCTMD Talking Points

The STRENGTH Trial

June 02, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

Todd Neale

January 28, 2021

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

L.A. McKeown

January 15, 2021

Advertisement

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

British Medical Groups Express Concern About Inclisiran Rollout

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

Less Cancer Among HF Patients Taking Statins, Registry Shows

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

The STRENGTH Trial

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Prediabetes Linked to Higher MACE Risk

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

Hospitalization for HF After Acute MI More Common in Women Than Men

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content